Moderna’s COVID-19 Vaccine Found 94.5% Effective [09 December, 2020]

Produced by the US company Moderna and in collaboration with the US government’s Operation Warp Speed, a novel vaccine for SARS-CoV-2 has shown 94.5% efficacy according to preliminary results.

The vaccine reportedly has a shelf life of up to 30 days in a commercial refrigerator and can stand being at room temperature for up to 12 hours. And at -4 degrees Fahrenheit (-20 degrees Celsius) it remains viable for up to six months.

These findings suggest that it’s significantly easier to store and transport this vaccine around when compared to the recent Pfizer/BioNTech vaccine—which was announced about a week ago and has 90% efficacy.

Read More

0 0 vote
Article Rating